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1182with these reports and adds supportive long-term
information.
Dr. Kajimoto and colleagues point out that the lower
number of bypasses in our OPCAB group is a limitation
and suggest the possibility of different outcomes with
more competent hands. However, they provide no
evidence of equal or greater numbers of bypasses with
OPCAB compared with on-pump CABG in the Japanese
registry. The early OPCAB outcomes in the Japanese
registry are excellent, but so are the OPCAB outcomes
of experienced surgeons throughout the world. Our
question was whether the early beneﬁts of OPCAB are
more sustainable over signiﬁcantly longer periods
than on-pump CABG, and our results cast doubts on
this possibility. Again, Dr. Kajimoto and colleagues
provide no evidence showing superior long-term
beneﬁts in terms of reduced mortality with OPCAB
over on-pumpCABG in the Japanese registry. If a lower
number of bypass grafts is a technical limitation of
OPCAB, perhaps surgeons should revise their strategy
accordingly to ensure superior bypass quality and
completeness of revascularization (3–5), especially in
light of recent studies, including ours that support this
viewpoint.
With regard to possible bias in coronary lesion
severity, the 2 groups in our study were matched by a
rigorous process of statistical veriﬁcation, including
propensity score matching and inverse probability
weighting. If there was any bias in lesion severity, the
inclination would have been toward on-pump CABG
rather than OPCAB.
Finally, Dr. Kajimoto and colleagues question the
quality of our OPCAB data and, by extension, the
reliability of our study by pointing that “South
Korean surgeons were still acquiring the required
techniques.” We would like to note that our study
was not a registry outcome analysis (i.e., a Korean
registry), as erroneously alluded to by Kajimoto
et al., but rather a single institutional analysis of the
outcomes of experienced surgeons. Our single insti-
tutional study draws on a population of more than
5,000 patients with isolated CABG, including more
than 2,000 patients who underwent OPCAB. Ques-
tioning the experience and expertise of surgeons in
such a setting places a higher standard than that
considered more than acceptable internationally.
The OPCAB data derived from surgeons showing an
on-pump conversion rate of 2% and early mortality
rate of 0.9% can hardly be seen as premature or
inadequate by any standards in published research,
even from Japan. Unless the credibility of our report
itself is in question, which would be another matter,
the confusion of Dr. Kajimoto and colleagues
regarding the details and design of our report uponwhich their hasty conclusions were based warrants
careful re-perusal of the contents.Joon Bum Kim, MD, PhD
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63:2280–8.How to Determine a
Metabolically Healthy
Body Composition in
Cardiovascular DiseaseWe read the recent paper by Chang et al. (1) with great
interest. The investigators observed that the so-called
metabolically healthy obesity (MHO) phenotype was
associated with subclinical coronary atherosclerosis
(CA) in 14,828 healthy subjects. CA was identiﬁed by
cardiac computed tomography and calculation of the
coronary artery calciﬁcation (CAC) score. The
investigators conclude that MHO per se is harmful
and the term “metabolically healthy” in obese
patients is a mere artefact. This interpretation of the
data, however, is arguable on several counts.
In the consensus document on CAC scoring, a score
ranging 1 to 112 is considered to indicate mild risk and a
score of 1,000 to indicate very high risk of cardiovas-
cular (CV) events; a score $400 is equivalent to an
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1183intermediate risk in asymptomatic patients (2). In
contrast, in the current paper, a cutoff CAC score of
>80 was used to investigate a higher CV risk.
The investigators do not provide the frequency
distribution of the CAC score or the mean value in
this patient group with a score >80. If a skewed
distribution of CAC scores may be assumed with
many patients having a score <112 and the
majority <400, the reported CAC score-grouping >80
by itself means nothing for a person’s individual risk.
The frequency of a CAC score >80 was roughly
doubled in the MHO group compared with normal
weight subjects. However, metabolically relevant risk
factors such as smoking and alcohol intake were also
almost doubled in the MHO group compared with
normal weight subjects, and the proportion of men
(who have a higher risk of CV disease than women)
was almost 3 times higher. Thus, does the risk of CA
in the MHO group really rely on obesity and not on
other factors?
In addition, the investigators split the study
population into 4 groups for body mass index
(BMI) according to the Asian-speciﬁc criteria, in which
people with a BMI$25 kg/m2 are considered obese and
those with a BMI of 23 to 25 kg/m2 are considered
overweight. This is in contrast to the World Health
Organization criteria for overweight (BMI of 25 to 30
kg/m2) and obesity (BMI $30 kg/m2) (3). This shift
toward lower cutoff values may inﬂuence the results
of the report and thus render the ﬁndings less
applicable for Western populations.
Finally, it may be challenged that a BMI of 18.5 to
23 kg/m2 represents subjects with optimum metabolic
health with regard to optimum survival as the most
relevant clinical endpoint. In multiple epidemiolog-
ical studies, the nadir of the U-shaped association
between body weight and longevity was clearly
around a BMI of 25 kg/m2 or slightly higher (4), with a
signiﬁcant increased risk for patients with a BMI
<22 kg/m2 (5). Notably, in patients with some degree
of CV disease, such as those with chronic heart
failure, the presence of overweight and mild obesity
is, in fact, a very positive prognosticator independent
of other metabolic and clinical variables (6,7).Nadja Scherbakov, MD
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Obese Versus
Cardiorespiratory Fit Obese:
Is It Time to Bring
Them Together?During the past decade, the term “metabolically
healthy obesity” (MHO) has been used in published
reports. This phrase has gained popularity over the
past year in particular, appearing in approximately
19 papers in PubMed thus far in 2014, not to mention
the recent high-proﬁle Whitehall II cohort study by
Hinnouho et al. (1).
The obesity paradox focuses on the fact that as
various parameters of body composition (such as body
mass index) increase, there seem to be mortality ben-
eﬁts, especially in patients with coronary artery dis-
ease, heart failure, pulmonary hypertension, and
chronic obstructive pulmonary disease (2). It has also
been shown that cardiorespiratory ﬁtness (CRF)
markedly alters the relationship between adiposity
and subsequent prognosis (2–5). A recent paper by
Myers et al. (6) highlighted that CRF has not gained
the same positioning as other risk factors, despite the
emphasis on the importance of CRF by the American
Heart Association (7) and other professional
organizations. However, these seemingly paradoxical
